Experts urge disclosure of clinical trial recruitment data

01/3/2012 | PharmaTimes (U.K.)

Information on clinical trial recruitment targets and investigators' performance should be publicly disclosed to registries such as, writes Rafael Dal-Ré from the Pasqual Maragall Foundation, as well as other academic and clinical trial professionals, in the open-access journal PloS Medicine. Disclosure of such information would help researchers conducting meta-analyses as well as patient advocates, trial sponsors, health officials, review boards and hospital managers, they write.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC